Abstract
BackgroundThe use of biological products in the therapy of juvenile idiopathic arthritis (JIA) enables to achieve sustained remission of the disease and to improve the prognosis.ObjectivesTo assess efficacy and safety...
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
